Clinical Trial

Compassionate Administration of ZVS101e for Extended Treatment

Name: Compassionate Administration of ZVS101e for Extended Treatment — clinical trial record (NCT07307469)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

To provide treatment options for the control group of subjects who completed the 52-week follow-up of the Phase III clinical trial (Protocol number: ZYA-2024-001) of ZVS101e in subjects with Bietti crystalline corneoretinal dystrophy (BCD).

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-06-18

Trial Details

NCT Number	NCT07307469
Lead Sponsor	Chigenovo Co., Ltd
Conditions	Bietti Crystalline Corneoretinal Dystrophy
Enrollment	32 participants
Start Date	2026-07
Primary Completion	2027-01 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-17